| 2020 |
Miller PD, Pannacciulli N, Malouf-Sierra J, Singer A, Czerwiński E, Bone HG, Wang C, Huang S, Chines A, Lems W, Brown JP. Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates. Osteoporos Int. January 2020;31(1):181-191. |
0 |
0 |
| 2020 |
Javaid MK, Sami A, Lems W, Mitchell P, Thomas T, Singer A, Speerin R, Fujita M, Pierroz DD, Akesson K, Halbout P, Ferrari S, Cooper C. A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network. Osteoporos Int. July 2020;31(7):1193-1204. |
6 |
2 |
| 2020 |
Lewiecki EM, Wright NC, Singer AJ. Racial disparities, FRAX, and the care of patients with osteoporosis. Osteoporos Int. November 2020;31(11):2069-2071. |
0 |
0 |
| 2021 |
Fuggle NR, Singer A, Gill C, Patel A, Medeiros A, Mlotek AS, Pierroz DD, Halbout P, Harvey NC, Reginster J-Y, Cooper C, Greenspan SL. How has COVID-19 affected the treatment of osteoporosis? an IOF-NOF-ESCEO global survey. Osteoporos Int. April 2021;32(4):611-617. |
3 |
2 |
| 2021 |
Singer AJ, Fuggle NR, Gill CB, Patel AR, Medeiros AP, Greenspan SL. COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey. Osteoporos Int. April 2021;32(4):619-622. |
1 |
1 |
| 2021 |
Fuggle NR, Singer A, Gill C, Patel A, Medeiros A, Mlotek AS, Pierroz DD, Halbout P, Harvey NC, Reginster J-Y, Cooper C, Greenspan SL. Correction to: How has COVID-19 affected the treatment of osteoporosis? an IOF-NOF-ESCEO global survey. Osteoporos Int. April 2021;32(4):801-801. |
1 |
0 |